Regulation of STIM1, store-operated Ca2+ influx, and nitric oxide generation by retinoic acid in rat mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 3, 2007, Pages

  Zhang, Wanke ^a   Meng, Hua ^a,d   Li, Zhen Hua ^a   Shu, Zhenju ^a   Ma, Xiuye ^b   Zhang, Bin Xian ^a,c  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; eNOS; Glomerular hyperfiltration; Lactacystin; Proteasome; Protein downregulation

Indexed keywords

CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; LACTACYSTIN; MEMBRANE PROTEIN; MESSENGER RNA; PROTEASOME; PROTEIN STIM 1; RETINOIC ACID; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR CALCIUM; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAFILTRATION; WESTERN BLOTTING;

EID: 33847783375     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00286.2006     Document Type: Article

References (55)

1. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol Renal Fluid Electrolyte Physiol 268: F885-F898, 1995.
2. Baylis C, Atzpodien EA, Freshour G, Engels K. Peroxisome proliferator-activated receptor γ agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J Pharmacol Exp Ther 307: 854-860, 2003.
3. Campos AH, Calixto JB, Schor N. Bradykinin induces a calcium-store-dependent calcium influx in mouse mesangial cells. Nephron 91: 308-315, 2002.
4. Cesario RM, Klausing K, Razzaghi H, Crombie D, Rungta D, Heyman RA, Lala DS. The rexinoid LG100754 is a novel RXR:PPARγ agonist and decreases glucose levels in vivo. Mol Endocrinol 15: 1360-1369, 2001.
5. Dechow C, Morath C, Peters J, Lehrke I, Waldherr R, Haxsen V, Ritz E, Wagner J. Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis. Am J Physiol Renal Physiol 281: F909-F919, 2001.
6. Dragnev KH, Freemantle SJ, Spinella MJ, Dmitrovsky ETHA. Cyclin proteolysis as a retinoid cancer prevention mechanism. Ann NY Acad Sci 952: 13-22, 2001.
7. el-Dahr SS, Dipp S, Yosipiv IV, Baricos WH. Bradykinin stimulates c-fos expression, AP-1-DNA binding activity and proliferation of rat glomerular mesangial cells. Kidney Int 50: 1850-1855, 1996.
8. 2+ signaling in high glucose is due to inactivation of phospholipase C-β3 by protein kinase C. Am J Physiol Renal Physiol 289: F1078-F1087, 2005.
9. Furusu A, Miyazaki M, Abe K, Tsukasaki S, Shioshita K, Sasaki O, Miyazaki K, Ozono Y, Koji T, Harada T, Sakai H, Kohno S. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 53: 1760-1768, 1998.
10. Gooch JL, Gorin Y, Zhang BX, Abboud HE. Involvement of calcineurin in transforming growth factor-β-mediated regulation of extracellular matrix accumulation. J Biol Chem 279: 15561-15570, 2004.
11. Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, Kang SW, Han DS, Han JY, Cha DR. Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol 82: 568-576, 2004.
12. Hoshiyama M, Li B, Yao J, Harada T, Morioka T, Oite T. Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp Nephrol 95: e62-e68, 2003.
13. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981.
14. Kakoki M, Takahashi N, Jennette JC, Smithies O. Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci USA 101: 13302-13305, 2004.
15. Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 284: F1121-F1137, 2003.
16. 2+ influx. Biochem J 330: 695-699, 1998.
17. Lenhard JM, Lancaster ME, Paulik MA, Weiel JE, Binz JG, Sundseth SS, Gaskill BA, Lightfoot RM, Brown HR. The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction. Diabetologia 42: 545-554, 1999.
18. Li X, Hansen PA, Xi L, Chandraratna RAS, Burant CF. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor γ and retinoic acid x receptors. J Biol Chem 280: 38317-38327, 2005.
19. 2+ entry. J Biol Chem 275: 17979-17985, 2000.
20. 2+ influx. Curr Biol 15: 1235-1241, 2005.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001.
22. McGowan TA, Zhu Y, Sharma K. Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy. Curr Diab Rep 4: 447-454, 2004.
23. 2+ influx involves the type III IP3 receptor and regulates actin cytoskeleton. Am J Physiol Renal Physiol 282: F910-F920, 2002.
24. Michellys PY, Ardecky RJ, Chen JH, Crombie DL, Etgen GJ, Faul MF, Faulkner AL, Grese TA, Heyman RA, Karanewsky DS, Klausing K, Leibowitz MD, Liu S, Mais DA, Mapes CM, Marschke K, Reifel-Miller A, Ogilvie KM, Rungta D, Thompson AW, Tyhonas JS, Boehm MF. Novel (2E,4E,6Z)-7-(2-alkoxy-3,5- dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes. J Med Chem 46: 2683-2696, 2003.
25. Mogensen CE. Glomerular filtration rate and renal plasma flow in short term and long term juvenile diabetes mellitus. Scand J Clin Invest 28: 91-100, 1971.
26. Morath CHRI, Dechow CLAU, Lehrke INGO, Haxsen VOLK, Waldherr RUDI, Floege JURG, Ritz EBER, Wagner JURG. Effects of retinoids on the TGF-β system and extracellular matrix in experimental glomerulonephritis. J Am Soc Nephrol 12: 2300-2309, 2001.
27. Nutt LK, O'Neil RG. Effect of elevated glucose on endothelin-induced store-operated and nonstore-operated calcium influx in renal mesangial cells. J Am Soc Nephrol 11: 1225-1235, 2000.
28. Oseto S, Moriyama T, Kawada N, Nagatoya K, Takeji M, Ando A, Yamamoto T, Imai E, Hori M. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Kidney Int 64: 1241-1252, 2003.
29. Ouardani M, Travo P, Rakotoarivony J, Leung-Tack J. Decrease of bradykinin-induced glomerular contraction in diabetic rat: a new cellular interpretation. Eur J Cell Biol 73: 232-239, 1997.
30. Pickart CM, Cohen RE. Proteasomes and their kin: proteases in the machine agE. Nat Rev Mol Cell Biol 5: 177-187, 2004.
31. Portero-Otin M, Pamplona R, Ruiz MC, Cabiscol E, Prat J, Bellmunt MJ. Diabetes induces an impairment in the proteolytic activity against oxidized proteins and a heterogeneous effect in nonenzymatic protein modifications in the cytosol of rat liver and kidney. Diabetes 48: 2215-2220, 1999.
32. Ralph DeFronzo A. Diabetic nephropathy: etiologic and therapeutic considerations. Diabetes Rev 3: 510-564, 1995.
33. 2+ channel function. J Cell Biol 169: 435-445, 2005.
34. Sabbioni S, Veronese A, Trubia M, Taramelli R, Barbanti-Brodano G, Croce CM, Negrini M. Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD. Cytogenetic Genome Res 86: 214-218, 1999.
35. Schaier M, Liebler S, Schade K, Shimizu F, Kawachi H, Grone HJ, Chandraratna R, Ritz E, Wagner J. Retinoic acid receptor a and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med 82: 116-125, 2004.
36. Shultz PJ, DiCorleto PE, Silver BJ, Abboud HE. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol Renal Fluid Electrolyte Physiol 255: F674-F684, 1988.
37. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
38. Song Q, Wang DZ, Harley RA, Chao L, Chao J. Cellular localization of low-molecular-weight kininogen and bradykinin B2 receptor mRNAs in human kidney. Am J Physiol Renal Fluid Electrolyte Physiol 270: F919-F926, 1996.
39. Soprano DR, Qin P, Soprano KJ. Retinoic acid receptors and cancers. Annu Rev Nutr 24: 201-221, 2004.
40. 2+ channels. Proc Natl Acad Sci USA 103: 4040-4045, 2006.
41. Srinivasan S, Hatley ME, Bolick DT, Palmer LA, Edelstein D, Brownlee M, Hedrick CC. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 47: 1727-1734, 2004.
42. Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K, Wada J, Makino H. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 41: 1426-1434, 1998.
43. Tan Y, Wang B, Keum JS, Jaffa AA. Mechanisms through which bradykinin promotes glomerular injury in diabetes. Am J Physiol Renal Physiol 288: F483-F492, 2005.
44. Tang Y, Li GD. Chronic exposure to high glucose impairs bradykinin-stimulated nitric oxide production by interfering with the phospholipase-C-implicated signalling pathway in endothelial cells: evidence for the involvement of protein kinase C. Diabetologia 47: 2093-2104, 2004.
45. Thomson SC, Deng A, Komine N, Hammes JS, Blantz RC, Gabbai FB. Early diabetes as a model for testing the regulation of juxtaglomerular NOS I. Am J Physiol Renal Physiol 287: F732-F738, 2004.
46. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol Renal Fluid Electrolyte Physiol 265: F886-F895, 1993.
47. Veelken ROLA, Hilgers KF, Hartner ANDR, Haas ALEX, Bohmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 11: 71-79, 2000.
48. Vuligonda V, Thacher SM, Chandraratna RAS. Enantioselective syntheses of potent retinoid x receptor ligands: differential biological activities of individual antipodes. J Med Chem 44: 2298-2303, 2001.
49. Wagner JURG, Dechow CLAU, Morath CHRI, Lehrke INGO, Amann KERS, Waldherr RUDI, Floege JURG, Ritz EBER. Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol 11: 1479-1487, 2000.
50. Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular complications. Diabet Med 18: 945-959, 2001.
51. Zancai P, Dal Col J, Piccinin S, Guidoboni M, Cariati R, Rizzo S, Boiocchi M, Maestro R, Dolcetti R. Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins. Oncogene 24: 2483-2494, 2005.
52. 2+ entry in a human salivary cell line. J Biol Chem 277: 48165-48171, 2002.
53. 2+ store to the plasma membrane. Nature 437: 902-905, 2005.
54. Zhang WK, Shen YG, He XJ, Du BX, Xie ZM, Luo GZ, Zhang JS, Chen SY. Characterization of a novel cell cycle-related gene from Arabidopsis. J Exp Bot 56: 807-816, 2005.
55. Ziyadeh FN. Mediators of diabetic renal disease: the case for TGF-β as the major mediator. J Am Soc Nephrol 15: S55-S57, 2004.